Gapping down
Other news:
- MEIP -13.3% (MEI Pharma and Helsinn Healthcare SA discontinue the phase 3 Study with pracinostat in AML after completing interim analysis)
- BLFS -7.7% (prices 5.175 mln common stock offering at $14.50/share)
- PLYA -4.4% (stock offering by selling stockholders)
- AKRO -2.2% (files for $300 mln mixed securities shelf offering)
- VXX -1.9% (trading lower with futures stronger)
- NVS -0.7% (resolves legacy litigation matters, finalizing settlement of speaker program litigation with US Government)
Analyst comments:
- NGG -2.5% (downgraded to Hold from Buy at HSBC Securities)
- LVGO -2.3% (downgraded to Neutral from Buy at Goldman)
- TEF -0.8% (downgraded to Hold from Buy at HSBC Securities)